[1] E.J. Benjamin, M.J. Blaha, S.E. Chiuve, M. Cushman, S.R. Das, R. Deo, S.D. de Ferranti, J. Floyd, M. Fornage, C. Gillespie, C.R. Isasi, M.C. Jimenez, L.C. Jordan, S.E. Judd, D. Lackland, J.H. Lichtman, L. Lisabeth, S. Liu, C.T. Longenecker, R.H. Mackey, K. Matsushita, D. Mozaffarian, M.E. Mussolino, K. Nasir, R.W. Neumar, L. Palaniappan, D.K. Pandey, R.R. Thiagarajan, M.J. Reeves, M. Ritchey, C.J. Rodriguez, G.A. Roth, W.D. Rosamond, C. Sasson, A. Towfighi, C.W. Tsao, M.B. Turner, S.S. Virani, J.H. Voeks, J.Z. Willey, J.T. Wilkins, J.H. Wu, H.M. Alger, S.S. Wong, P. Muntner, C. American Heart Association Statistics, S. Stroke Statistics, Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association, Circulation 135(10) (2017) e146-e603.
[2] M.A. Kohn, E. Kwan, M. Gupta, J.A. Tabas, Prevalence of acute myocardial infarction and other serious diagnoses in patients presenting to an urban emergency department with chest pain, The Journal of emergency medicine 29(4) (2005) 383-90.
[3] M.S. Klinkman, D. Stevens, D.W. Gorenflo, Episodes of care for chest pain: a preliminary report from MIRNET. Michigan Research Network, The Journal of family practice 38(4) (1994) 345-52.
[4] M.J. Pencina, R.B. D'Agostino, Sr., M.G. Larson, J.M. Massaro, R.S. Vasan, Predicting the 30-year risk of cardiovascular disease: the framingham heart study, Circulation 119(24) (2009) 3078-84.
[5] M.R. Patel, E.D. Peterson, D. Dai, J.M. Brennan, R.F. Redberg, H.V. Anderson, R.G. Brindis, P.S. Douglas, Low diagnostic yield of elective coronary angiography, The New England journal of medicine 362(10) (2010) 886-95.
[6] V.L. Roger, A.S. Go, D.M. Lloyd-Jones, R.J. Adams, J.D. Berry, T.M. Brown, M.R. Carnethon, S. Dai, G. de Simone, E.S. Ford, C.S. Fox, H.J. Fullerton, C. Gillespie, K.J. Greenlund, S.M. Hailpern, J.A. Heit, P.M. Ho, V.J. Howard, B.M. Kissela, S.J. Kittner, D.T. Lackland, J.H. Lichtman, L.D. Lisabeth, D.M. Makuc, G.M. Marcus, A. Marelli, D.B. Matchar, M.M. McDermott, J.B. Meigs, C.S. Moy, D. Mozaffarian, M.E. Mussolino, G. Nichol, N.P. Paynter, W.D. Rosamond, P.D. Sorlie, R.S. Stafford, T.N. Turan, M.B. Turner, N.D. Wong, J. Wylie-Rosett, Heart Disease and Stroke Statistics--2011 Update: A Report From the American Heart Association, Circulation (2010).
[7] P.M. Farrehi, S.J. Bernstein, M. Rasak, S.A. Dabbous, R.J. Stomel, K.A. Eagle, M. Rubenfire, Frequency of negative coronary arteriographic findings in patients with chest pain is related to community practice patterns, The American journal of managed care 8(7) (2002) 643-8.
[8] B. Phibbs, T. Fleming, G.A. Ewy, S. Butman, J. Ambrose, R. Gorlin, E. Orme, J. Mason, Frequency of normal coronary arteriograms in three academic medical centers and one community hospital, Am J Cardiol 62(7) (1988) 472-4.
[9] S. Minha, S. Behar, R. Krakover, V. Boyko, Z. Vered, A. Blatt, Characteristics and outcome of patients with acute coronary syndrome and normal or near-normal coronary angiography, Coronary artery disease 21(4) (2010) 212-6.
[10] A.M. From, G. Kane, C. Bruce, P.A. Pellikka, C. Scott, R.B. McCully, Characteristics and outcomes of patients with abnormal stress echocardiograms and angiographically mild coronary artery disease (<50% stenoses) or normal coronary arteries, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 23(2) (2010) 207-14.
[11] S. Rosenberg, M.R. Elashoff, P. Beineke, S.E. Daniels, J.A. Wingrove, W.G. Tingley, P.T. Sager, A.J. Sehnert, M. Yau, W.E. Kraus, L.K. Newby, R.S. Schwartz, S. Voros, S.G. Ellis, N. Tahirkheli, R. Waksman, J. McPherson, A. Lansky, M.E. Winn, N.J. Schork, E.J. Topol, Multicenter validation of the diagnostic accuracy of a blood-based gene expression test for assessing obstructive coronary artery disease in nondiabetic patients, Ann Intern Med 153(7) (2010) 425-34.
[12] M.R. Elashoff, J.A. Wingrove, P. Beineke, S.E. Daniels, W.G. Tingley, S. Rosenberg, S. Voros, W.E. Kraus, G.S. Ginsburg, R.S. Schwartz, S.G. Ellis, N. Tahirkheli, R. Waksman, J. McPherson, A.J. Lansky, E.J. Topol, Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients, BMC medical genomics 4 (2011) 26.
[13] T. Huan, B. Zhang, Z. Wang, R. Joehanes, J. Zhu, A.D. Johnson, S. Ying, P.J. Munson, N. Raghavachari, R. Wang, P. Liu, P. Courchesne, S.J. Hwang, T.L. Assimes, R. McPherson, N.J. Samani, H. Schunkert, A.G.w.R. Coronary, I.C.f.B.P.G. Meta-analysis Consortium, Q. Meng, C. Suver, C.J. O'Donnell, J. Derry, X. Yang, D. Levy, A systems biology framework identifies molecular underpinnings of coronary heart disease, Arterioscler Thromb Vasc Biol 33(6) (2013) 1427-34.
[14] P.R. Sinnaeve, M.P. Donahue, P. Grass, D. Seo, J. Vonderscher, S.D. Chibout, W.E. Kraus, M. Sketch, Jr., C. Nelson, G.S. Ginsburg, P.J. Goldschmidt-Clermont, C.B. Granger, Gene expression patterns in peripheral blood correlate with the extent of coronary artery disease, PloS one 4(9) (2009) e7037.
[15] J.A. Wingrove, S.E. Daniels, A.J. Sehnert, W. Tingley, M.R. Elashoff, S. Rosenberg, L. Buellesfeld, E. Grube, L.K. Newby, G.S. Ginsburg, W.E. Kraus, Correlation of peripheral-blood gene expression with the extent of coronary artery stenosis, Circ Cardiovasc Genet 1(1) (2008) 31-8.
[16] L. Li, L. Ying, M. Naesens, W. Xiao, T. Sigdel, S. Hsieh, J. Martin, R. Chen, K. Liu, M. Mindrinos, R. Davis, M. Sarwal, Interference of globin genes with biomarker discovery for allograft rejection in peripheral blood samples, Physiological genomics 32(2) (2008) 190-7.
[17] D.C. Goff, Jr., D.M. Lloyd-Jones, G. Bennett, S. Coady, R.B. D'Agostino, R. Gibbons, P. Greenland, D.T. Lackland, D. Levy, C.J. O'Donnell, J.G. Robinson, J.S. Schwartz, S.T. Shero, S.C. Smith, Jr., P. Sorlie, N.J. Stone, P.W. Wilson, H.S. Jordan, L. Nevo, J. Wnek, J.L. Anderson, J.L. Halperin, N.M. Albert, B. Bozkurt, R.G. Brindis, L.H. Curtis, D. DeMets, J.S. Hochman, R.J. Kovacs, E.M. Ohman, S.J. Pressler, F.W. Sellke, W.K. Shen, S.C. Smith, Jr., G.F. Tomaselli, G. American College of Cardiology/American Heart Association Task Force on Practice, 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Circulation 129(25 Suppl 2) (2014) S49-73.
[18] J.K. Min, A. Dunning, H. Gransar, S. Achenbach, F.Y. Lin, M. Al-Mallah, M.J. Budoff, T.Q. Callister, H.J. Chang, F. Cademartiri, E. Maffei, K. Chinnaiyan, B.J. Chow, R. D'Agostino, A. DeLago, J. Friedman, M. Hadamitzky, J. Hausleiter, S.W. Hayes, P. Kaufmann, G.L. Raff, L.J. Shaw, L. Thomson, T. Villines, R.C. Cury, G. Feuchtner, Y.J. Kim, J. Leipsic, D.S. Berman, M. Pencina, Medical History for Prognostic Risk Assessment and Diagnosis of Stable Patients with Suspected Coronary Artery Disease, Am J Med (2015).
[19] A. Menke, M. Rex-Haffner, T. Klengel, E.B. Binder, D. Mehta, Peripheral blood gene expression: it all boils down to the RNA collection tubes, BMC Res Notes 5 (2012) 1.
[20] L. Shi, L.H. Reid, W.D. Jones, R. Shippy, J.A. Warrington, S.C. Baker, P.J. Collins, F. de Longueville, E.S. Kawasaki, K.Y. Lee, Y. Luo, Y.A. Sun, J.M. Willey, R.A. Setterquist, G.M. Fischer, W. Tong, Y.P. Dragan, D.J. Dix, F.W. Frueh, F.M. Goodsaid, D. Herman, R.V. Jensen, C.D. Johnson, E.K. Lobenhofer, R.K. Puri, U. Schrf, J. Thierry-Mieg, C. Wang, M. Wilson, P.K. Wolber, L. Zhang, W. Slikker, Jr., L. Shi, L.H. Reid, The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements, Nat. Biotechnol. 24(9) (2006) 1151-61.
[21] J.A. Ladapo, M. Budoff, D. Sharp, M. Zapien, L. Huang, B. Maniet, L. Herman, M. Monane, Clinical Utility of a Precision Medicine Test Evaluating Outpatients with Suspected Obstructive Coronary Artery Disease, Am J Med (2016).
[22] J. Eng, ROC Analysis: web-based calculator for ROC curves., 2014. http://www.jrocfit.org.
[23] N.B. Larson, C. Berardi, P.A. Decker, C.L. Wassel, P.S. Kirsch, J.S. Pankow, M.M. Sale, M. de Andrade, H. Sicotte, W. Tang, N.Q. Hanson, M.Y. Tsai, K.D. Taylor, S.J. Bielinski, Trans-ethnic meta-analysis identifies common and rare variants associated with hepatocyte growth factor levels in the Multi-Ethnic Study of Atherosclerosis (MESA), Ann Hum Genet 79(4) (2015) 264-74.
[24] C.W. McDonough, Y. Gong, S. Padmanabhan, B. Burkley, T.Y. Langaee, O. Melander, C.J. Pepine, A.F. Dominiczak, R.M. Cooper-Dehoff, J.A. Johnson, Pharmacogenomic association of nonsynonymous SNPs in SIGLEC12, A1BG, and the selectin region and cardiovascular outcomes, Hypertension 62(1) (2013) 48-54.
[25] X. Lu, L. Wang, S. Chen, L. He, X. Yang, Y. Shi, J. Cheng, L. Zhang, C.C. Gu, J. Huang, T. Wu, Y. Ma, J. Li, J. Cao, J. Chen, D. Ge, Z. Fan, Y. Li, L. Zhao, H. Li, X. Zhou, L. Chen, D. Liu, J. Chen, X. Duan, Y. Hao, L. Wang, F. Lu, Z. Liu, C. Yao, C. Shen, X. Pu, L. Yu, X. Fang, L. Xu, J. Mu, X. Wu, R. Zheng, N. Wu, Q. Zhao, Y. Li, X. Liu, M. Wang, D. Yu, D. Hu, X. Ji, D. Guo, D. Sun, Q. Wang, Y. Yang, F. Liu, Q. Mao, X. Liang, J. Ji, P. Chen, X. Mo, D. Li, G. Chai, Y. Tang, X. Li, Z. Du, X. Liu, C. Dou, Z. Yang, Q. Meng, D. Wang, R. Wang, J. Yang, H. Schunkert, N.J. Samani, S. Kathiresan, M.P. Reilly, J. Erdmann, A.D.G.-W.R. Coronary, C. Meta-Analysis, X. Peng, X. Wu, D. Liu, Y. Yang, R. Chen, B. Qiang, D. Gu, Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease, Nat Genet 44(8) (2012) 890-4.
[26] J.R. Choi, Y. Jang, S. Kim Yoon, J.K. Park, S.R. Sorn, M.Y. Park, M. Lee, The Impact of CDH13 Polymorphism and Statin Administration on TG/HDL Ratio in Cardiovascular Patients, Yonsei Med J 56(6) (2015) 1604-12.
[27] M. Putku, M. Kals, R. Inno, S. Kasela, E. Org, V. Kozich, L. Milani, M. Laan, CDH13 promoter SNPs with pleiotropic effect on cardiometabolic parameters represent methylation QTLs, Hum Genet 134(3) (2015) 291-303.
[28] N. Solban, P. Dumas, F. Gossard, Y. Sun, M. Pravenec, V. Kren, R. Lewanczuk, P. Hamet, J. Tremblay, Chromosomal mapping of HCaRG, a novel hypertension-related, calcium-regulated gene, Folia Biol (Praha) 48(1) (2002) 9-14.
[29] Y.M. Park, M.A. Province, X. Gao, M. Feitosa, J. Wu, D. Ma, D. Rao, A.T. Kraja, Longitudinal trends in the association of metabolic syndrome with 550 k single-nucleotide polymorphisms in the Framingham Heart Study, BMC Proc 3 Suppl 7 (2009) S116.
[30] C.J. Lessard, S. Sajuthi, J. Zhao, K. Kim, J.A. Ice, H. Li, H. Ainsworth, A. Rasmussen, J.A. Kelly, M. Marion, S.Y. Bang, Y. Bin Joo, J. Choi, H.S. Lee, Y. Mo Kang, C.H. Suh, W. Tae Chung, S.K. Lee, J.Y. Choe, S. Cheol Shim, J. Hee Oh, Y. Jin Kim, B.G. Han, N. Shen, H. Siew Howe, E.K. Wakeland, Q.Z. Li, Y. Wook Song, P.M. Gaffney, M.E. Alarcon-Riquelme, L.A. Criswell, C.O. Jacob, R.P. Kimberly, T.J. Vyse, J.B. Harley, K.L. Sivils, S.C. Bae, C.D. Langefeld, B.P. Tsao, Identification of a Systemic Lupus Erythematosus Risk Locus Spanning ATG16L2, FCHSD2, and P2RY2 in Koreans, Arthritis Rheumatol 68(5) (2016) 1197-209.
[31] J.A. Hubacek, V. Stanek, M. Gebauerova, R. Poledne, M. Aschermann, H. Skalicka, J. Matouskova, A. Kruger, M. Penicka, H. Hrabakova, J. Veselka, P. Hajek, V. Lanska, V. Adamkova, J. Pit ha, Rs6922269 marker at the MTHFD1L gene predict cardiovascular mortality in males after acute coronary syndrome, Mol Biol Rep 42(8) (2015) 1289-93.
[32] S. Saade, J.B. Cazier, M. Ghassibe-Sabbagh, S. Youhanna, D.A. Badro, Y. Kamatani, J. Hager, J.S. Yeretzian, G. El-Khazen, M. Haber, A.K. Salloum, B. Douaihy, R. Othman, N. Shasha, S. Kabbani, H.E. Bayeh, E. Chammas, M. Farrall, D. Gauguier, D.E. Platt, P.A. Zalloua, F. consortium, Large scale association analysis identifies three susceptibility loci for coronary artery disease, PloS one 6(12) (2011) e29427.
[33] M. Guardiola, H.J. Exeter, C. Perret, L. Folkersen, F. Van't Hooft, P. Eriksson, A. Franco-Cereceda, G. Paulsson-Berne, J. Palmen, K. Li, J.A. Cooper, K.T. Khaw, Z. Mallat, E. Ninio, S.A. Karabina, S.E. Humphries, S.M. Boekholdt, M.V. Holmes, P.J. Talmud, PLA2G10 Gene Variants, sPLA2 Activity, and Coronary Heart Disease Risk, Circ Cardiovasc Genet 8(2) (2015) 356-62.
[34] H. Ait-Oufella, O. Herbin, C. Lahoute, C. Coatrieux, X. Loyer, J. Joffre, L. Laurans, B. Ramkhelawon, O. Blanc-Brude, S. Karabina, C.A. Girard, C. Payre, K. Yamamoto, C.J. Binder, M. Murakami, A. Tedgui, G. Lambeau, Z. Mallat, Group X secreted phospholipase A2 limits the development of atherosclerosis in LDL receptor-null mice, Arterioscler Thromb Vasc Biol 33(3) (2013) 466-73.
[35] A. Clop, A. Bertoni, S.L. Spain, M.A. Simpson, V. Pullabhatla, R. Tonda, C. Hundhausen, P. Di Meglio, P. De Jong, A.C. Hayday, F.O. Nestle, J.N. Barker, R.J. Bell, F. Capon, R.C. Trembath, An in-depth characterization of the major psoriasis susceptibility locus identifies candidate susceptibility alleles within an HLA-C enhancer element, PloS one 8(8) (2013) e71690.
[36] H. Sun, Y. Xia, L. Wang, Y. Wang, X. Chang, PSORS1C1 may be involved in rheumatoid arthritis, Immunol Lett 153(1-2) (2013) 9-14.
[37] Z. Xie, V. Nagarajan, D.E. Sturdevant, S. Iwaki, E. Chan, L. Wisch, M. Young, C.M. Nelson, S.F. Porcella, K.M. Druey, Genome-wide SNP analysis of the Systemic Capillary Leak Syndrome (Clarkson disease), Rare Dis 1(1) (2013).
[38] V. Iotchkova, J. Huang, J.A. Morris, D. Jain, C. Barbieri, K. Walter, J.L. Min, L. Chen, W. Astle, M. Cocca, P. Deelen, H. Elding, A.E. Farmaki, C.S. Franklin, M. Franberg, T.R. Gaunt, A. Hofman, T. Jiang, M.E. Kleber, G. Lachance, J. Luan, G. Malerba, A. Matchan, D. Mead, Y. Memari, I. Ntalla, K. Panoutsopoulou, R. Pazoki, J.R. Perry, F. Rivadeneira, M. Sabater-Lleal, B. Sennblad, S.Y. Shin, L. Southam, M. Traglia, F. van Dijk, E.M. van Leeuwen, G. Zaza, W. Zhang, U.K. Consortium, N. Amin, A. Butterworth, J.C. Chambers, G. Dedoussis, A. Dehghan, O.H. Franco, L. Franke, M. Frontini, G. Gambaro, P. Gasparini, A. Hamsten, A. Issacs, J.S. Kooner, C. Kooperberg, C. Langenberg, W. Marz, R.A. Scott, M.A. Swertz, D. Toniolo, A.G. Uitterlinden, C.M. van Duijn, H. Watkins, E. Zeggini, M.T. Maurano, N.J. Timpson, A.P. Reiner, P.L. Auer, N. Soranzo, Discovery and refinement of genetic loci associated with cardiometabolic risk using dense imputation maps, Nat Genet (2016).
[39] H. Lu, P. Guo, [Plasma heparin cofactor II activity correlates with the incidence of in-stent restenosis after the intervention of arteriosclerosis obliterans in lower extremity], Zhong Nan Da Xue Xue Bao Yi Xue Ban 40(2) (2015) 177-81.
[40] J.C. Rau, C. Deans, M.R. Hoffman, D.B. Thomas, G.T. Malcom, A.W. Zieske, J.P. Strong, G.G. Koch, F.C. Church, Heparin cofactor II in atherosclerotic lesions from the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study, Exp Mol Pathol 87(3) (2009) 178-83.
[41] H. Foroughi Asl, H.A. Talukdar, A.S. Kindt, R.K. Jain, R. Ermel, A. Ruusalepp, K.D. Nguyen, R. Dobrin, D.F. Reilly, H. Schunkert, N.J. Samani, I. Braenne, J. Erdmann, O. Melander, J. Qi, T. Ivert, J. Skogsberg, E.E. Schadt, T. Michoel, J.L. Bjorkegren, C.A. Consortium, Expression quantitative trait Loci acting across multiple tissues are enriched in inherited risk for coronary artery disease, Circ Cardiovasc Genet 8(2) (2015) 305-15.
[42] S.K. Thomsen, A. Ceroni, M. van de Bunt, C. Burrows, A. Barrett, R. Scharfmann, D. Ebner, M.I. McCarthy, A.L. Gloyn, Systematic Functional Characterization of Candidate Causal Genes for Type 2 Diabetes Risk Variants, Diabetes (2016).
[43] Q. Chen, A. Coffey, S.G. Bourgoin, M. Gadina, Cytohesin binder and regulator augments T cell receptor-induced nuclear factor of activated T Cells.AP-1 activation through regulation of the JNK pathway, J Biol Chem 281(29) (2006) 19985-94.
[44] L. Wang, X. Ni, K.R. Covington, B.Y. Yang, J. Shiu, X. Zhang, L. Xi, Q. Meng, T. Langridge, J. Drummond, L.A. Donehower, H. Doddapaneni, D.M. Muzny, R.A. Gibbs, D.A. Wheeler, M. Duvic, Genomic profiling of Sezary syndrome identifies alterations of key T cell signaling and differentiation genes, Nat Genet 47(12) (2015) 1426-34.
[45] O. Silva, J. Crocetti, L.A. Humphries, J.K. Burkhardt, M.C. Miceli, Discs Large Homolog 1 Splice Variants Regulate p38-Dependent and -Independent Effector Functions in CD8+ T Cells, PloS one 10(7) (2015) e0133353.
[46] J.M. Choi, A.L. Bothwell, The nuclear receptor PPARs as important regulators of T-cell functions and autoimmune diseases, Mol Cells 33(3) (2012) 217-22.
[47] A.F. Koreishi, A.J. Saenz, D.O. Persky, H. Cui, A. Moskowitz, C.H. Moskowitz, J. Teruya-Feldstein, The role of cytotoxic and regulatory T cells in relapsed/refractory Hodgkin lymphoma, Appl Immunohistochem Mol Morphol 18(3) (2010) 206-11.
[48] A. Schmidt, X.M. Zhang, R.N. Joshi, S. Iqbal, C. Wahlund, S. Gabrielsson, R.A. Harris, J. Tegner, Human macrophages induce CD4(+)Foxp3(+) regulatory T cells via binding and re-release of TGF-beta, Immunol Cell Biol 94(8) (2016) 747-62.
[49] M.D. Sharma, L. Huang, J.H. Choi, E.J. Lee, J.M. Wilson, H. Lemos, F. Pan, B.R. Blazar, D.M. Pardoll, A.L. Mellor, H. Shi, D.H. Munn, An inherently bifunctional subset of Foxp3+ T helper cells is controlled by the transcription factor eos, Immunity 38(5) (2013) 998-1012.
[50] F. Pan, H. Yu, E.V. Dang, J. Barbi, X. Pan, J.F. Grosso, D. Jinasena, S.M. Sharma, E.M. McCadden, D. Getnet, C.G. Drake, J.O. Liu, M.C. Ostrowski, D.M. Pardoll, Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells, Science 325(5944) (2009) 1142-6.
[51] D.E. Nagata, H.A. Ting, K.A. Cavassani, M.A. Schaller, S. Mukherjee, C. Ptaschinski, S.L. Kunkel, N.W. Lukacs, Epigenetic control of Foxp3 by SMYD3 H3K4 histone methyltransferase controls iTreg development and regulates pathogenic T-cell responses during pulmonary viral infection, Mucosal Immunol 8(5) (2015) 1131-43.
[52] T. Maruyama, J. Li, J.P. Vaque, J.E. Konkel, W. Wang, B. Zhang, P. Zhang, B.F. Zamarron, D. Yu, Y. Wu, Y. Zhuang, J.S. Gutkind, W. Chen, Control of the differentiation of regulatory T cells and T(H)17 cells by the DNA-binding inhibitor Id3, Nat Immunol 12(1) (2011) 86-95.
[53] C. Huang, S. Martin, C. Pfleger, J. Du, J.H. Buckner, J.A. Bluestone, J.L. Riley, S.F. Ziegler, Cutting Edge: a novel, human-specific interacting protein couples FOXP3 to a chromatin-remodeling complex that contains KAP1/TRIM28, J Immunol 190(9) (2013) 4470-3.
[54] J. Huehn, M. Beyer, Epigenetic and transcriptional control of Foxp3+ regulatory T cells, Semin Immunol 27(1) (2015) 10-8.
[55] C. Palmer, M. Diehn, A.A. Alizadeh, P.O. Brown, Cell-type specific gene expression profiles of leukocytes in human peripheral blood, BMC genomics 7 (2006) 115.
[56] W. Wojakowski, U. Landmesser, R. Bachowski, T. Jadczyk, M. Tendera, Mobilization of stem and progenitor cells in cardiovascular diseases, Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 26(1) (2012) 23-33.
[57] G.P. Fadini, S. Maruyama, T. Ozaki, A. Taguchi, J. Meigs, S. Dimmeler, A.M. Zeiher, S. de Kreutzenberg, A. Avogaro, G. Nickenig, C. Schmidt-Lucke, N. Werner, Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis, PloS one 5(7) (2010) e11488.
[58] N. Werner, S. Kosiol, T. Schiegl, P. Ahlers, K. Walenta, A. Link, M. Bohm, G. Nickenig, Circulating endothelial progenitor cells and cardiovascular outcomes, The New England journal of medicine 353(10) (2005) 999-1007.
[59] G. Chironi, L. Walch, M.G. Pernollet, J. Gariepy, J. Levenson, F. Rendu, A. Simon, Decreased number of circulating CD34+KDR+ cells in asymptomatic subjects with preclinical atherosclerosis, Atherosclerosis 191(1) (2007) 115-20.
[60] M. Vasa, S. Fichtlscherer, A. Aicher, K. Adler, C. Urbich, H. Martin, A.M. Zeiher, S. Dimmeler, Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease, Circ Res 89(1) (2001) E1-7.
[61] S. Damani, A. Bacconi, O. Libiger, A.H. Chourasia, R. Serry, R. Gollapudi, R. Goldberg, K. Rapeport, S. Haaser, S. Topol, S. Knowlton, K. Bethel, P. Kuhn, M. Wood, B. Carragher, N.J. Schork, J. Jiang, C. Rao, M. Connelly, V.M. Fowler, E.J. Topol, Characterization of circulating endothelial cells in acute myocardial infarction, Science translational medicine 4(126) (2012) 126ra33.
[62] J. George, S. Schwartzenberg, D. Medvedovsky, M. Jonas, G. Charach, A. Afek, A. Shamiss, Regulatory T cells and IL-10 levels are reduced in patients with vulnerable coronary plaques, Atherosclerosis 222(2) (2012) 519-23.
[63] Q. Li, Peripheral Th17/Treg imbalance in patients with atherosclerotic cerebral infarction, International journal of clinical and experimental pathology 6(6) (2013) 1015-1027.
[64] A.L. Asare, S.A. Kolchinsky, Z. Gao, R. Wang, K. Raddassi, K. Bourcier, V. Seyfert-Margolis, Differential gene expression profiles are dependent upon method of peripheral blood collection and RNA isolation, BMC genomics 9 (2008) 474.
[65] L.A. Matheson, T.T. Duong, A.M. Rosenberg, R.S. Yeung, Assessment of sample collection and storage methods for multicenter immunologic research in children, J Immunol Methods 339(1) (2008) 82-9.
[66] J. Ren, L. Han, J. Tang, Y. Liu, X. Deng, Q. Liu, P. Hao, X. Feng, B. Li, H. Hu, H. Wang, Foxp1 is critical for the maintenance of regulatory T-cell homeostasis and suppressive function, PLoS Biol 17(5) (2019) e3000270.
[67] S. Namkoong, A. Ho, Y.M. Woo, H. Kwak, J.H. Lee, Systematic Characterization of Stress-Induced RNA Granulation, Mol Cell 70(1) (2018) 175-187 e8.
[68] F. Taschuk, S. Cherry, DEAD-Box Helicases: Sensors, Regulators, and Effectors for Antiviral Defense, Viruses 12(2) (2020).
[69] D. Weil, A. Piton, D. Lessel, N. Standart, Mutations in genes encoding regulators of mRNA decapping and translation initiation: links to intellectual disability, Biochem Soc Trans 48(3) (2020) 1199-1211.
[70] C. Vindry, D. Weil, N. Standart, Pat1 RNA-binding proteins: Multitasking shuttling proteins, Wiley Interdiscip Rev RNA 10(6) (2019) e1557.
[71] M. Eriksson, W.T. Brown, L.B. Gordon, M.W. Glynn, J. Singer, L. Scott, M.R. Erdos, C.M. Robbins, T.Y. Moses, P. Berglund, A. Dutra, E. Pak, S. Durkin, A.B. Csoka, M. Boehnke, T.W. Glover, F.S. Collins, Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome, Nature 423(6937) (2003) 293-8.
[72] S. Nussing, H.F. Koay, S. Sant, T. Loudovaris, S.I. Mannering, M. Lappas, D.U. Y, I.E. Konstantinov, S.P. Berzins, G.F. Rimmelzwaan, S.J. Turner, E.B. Clemens, D.I. Godfrey, T.H. Nguyen, K. Kedzierska, Divergent SATB1 expression across human life span and tissue compartments, Immunol Cell Biol 97(5) (2019) 498-511.
[73] T. Akimova, T. Zhang, D. Negorev, S. Singhal, J. Stadanlick, A. Rao, M. Annunziata, M.H. Levine, U.H. Beier, J.M. Diamond, J.D. Christie, S.M. Albelda, E.B. Eruslanov, W.W. Hancock, Human lung tumor FOXP3+ Tregs upregulate four "Treg-locking" transcription factors, JCI Insight 2(16) (2017).
[74] Y. Hsu, J.E. Garrison, S. Seo, V.C. Sheffield, The absence of BBSome function decreases synaptogenesis and causes ectopic synapse formation in the retina, Sci Rep 10(1) (2020) 8321.
[75] P. van der Harst, N. Verweij, Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease, Circ Res 122(3) (2018) 433-443.
[76] B. Tan, L. Liu, Y. Yang, Q. Liu, L. Yang, F. Meng, Low CPNE3 expression is associated with risk of acute myocardial infarction: A feasible genetic marker of acute myocardial infarction in patients with stable coronary artery disease, Cardiol J 26(2) (2019) 186-193.
[77] A.H. Allam, M. Charnley, K. Pham, S.M. Russell, Developing T cells form an immunological synapse for passage through the beta-selection checkpoint, J Cell Biol 220(3) (2021).
[78] R. Ross, J. Masuda, E.W. Raines, A.M. Gown, S. Katsuda, M. Sasahara, L.T. Malden, H. Masuko, H. Sato, Localization of PDGF-B protein in macrophages in all stages of atherogenesis., Science 248 (1990) 1009-1012.
[79] G.K. Hansson, Immune mechanisms in atherosclerosis, Arterioscler Thromb Vasc Biol 21(12) (2001) 1876-90.
[80] P. Libby, Y. Okamoto, V.Z. Rocha, E. Folco, Inflammation in atherosclerosis: transition from theory to practice, Circ J 74(2) (2010) 213-20.
[81] M.A.C. Depuydt, K.H.M. Prange, L. Slenders, T. Ord, D. Elbersen, A. Boltjes, S.C.A. de Jager, F.W. Asselbergs, G.J. de Borst, E. Aavik, T. Lonnberg, E. Lutgens, C.K. Glass, H.M. den Ruijter, M.U. Kaikkonen, I. Bot, B. Slutter, S.W. van der Laan, S. Yla-Herttuala, M. Mokry, J. Kuiper, M.P.J. de Winther, G. Pasterkamp, Microanatomy of the Human Atherosclerotic Plaque by Single-Cell Transcriptomics, Circ Res 127(11) (2020) 1437-1455.
[82] D.F. Ketelhuth, G.K. Hansson, Modulation of autoimmunity and atherosclerosis - common targets and promising translational approaches against disease, Circ J 79(5) (2015) 924-33.
[83] X. Cheng, X. Yu, Y.J. Ding, Q.Q. Fu, J.J. Xie, T.T. Tang, R. Yao, Y. Chen, Y.H. Liao, The Th17/Treg imbalance in patients with acute coronary syndrome, Clin Immunol 127(1) (2008) 89-97.
[84] M. Liu, L.J. Xu, J.X. Wu, Changes of circulating CD4(+)CD25(+)CD127(low) regulatory T cells in patients with acute coronary syndrome and its significance, Genet Mol Res 14(4) (2015) 15930-6.
[85] Z.D. Liu, L. Wang, F.H. Lu, H. Pan, Y.X. Zhao, S.J. Wang, S.W. Sun, C.L. Li, X.L. Hu, Increased Th17 cell frequency concomitant with decreased Foxp3+ Treg cell frequency in the peripheral circulation of patients with carotid artery plaques, Inflamm Res 61(10) (2012) 1155-65.
[86] T. Emoto, N. Sasaki, T. Yamashita, K. Kasahara, K. Yodoi, Y. Sasaki, T. Matsumoto, T. Mizoguchi, K. Hirata, Regulatory/effector T-cell ratio is reduced in coronary artery disease, Circ J 78(12) (2014) 2935-41.
[87] A.V. Potekhina, E. Pylaeva, S. Provatorov, N. Ruleva, V. Masenko, E. Noeva, T. Krasnikova, T. Arefieva, Treg/Th17 balance in stable CAD patients with different stages of coronary atherosclerosis, Atherosclerosis 238(1) (2015) 17-21.
[88] Y.C. Kim, K.K. Kim, E.M. Shevach, Simvastatin induces Foxp3+ T regulatory cells by modulation of transforming growth factor-beta signal transduction, Immunology 130(4) (2010) 484-93.
[89] A.L. Rodriguez-Perea, C.J. Montoya, S. Olek, C.A. Chougnet, P.A. Velilla, Statins increase the frequency of circulating CD4+ FOXP3+ regulatory T cells in healthy individuals, J Immunol Res 2015 (2015) 762506.
[90] H. Ait-Oufella, B.L. Salomon, S. Potteaux, A.K. Robertson, P. Gourdy, J. Zoll, R. Merval, B. Esposito, J.L. Cohen, S. Fisson, R.A. Flavell, G.K. Hansson, D. Klatzmann, A. Tedgui, Z. Mallat, Natural regulatory T cells control the development of atherosclerosis in mice, Nat Med 12(2) (2006) 178-80.
[91] T. Yamashita, N. Sasaki, K. Kasahara, K. Hirata, Anti-inflammatory and immune-modulatory therapies for preventing atherosclerotic cardiovascular disease, J Cardiol 66(1) (2015) 1-8.
[92] C. Spitz, H. Winkels, C. Burger, C. Weber, E. Lutgens, G.K. Hansson, N. Gerdes, Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential, Cell Mol Life Sci (2015).
[93] P.C. Roldan, M. Ratliff, R. Snider, L. Macias, R. Rodriguez, W. Sibbitt, C.A. Roldan, Aortic Atherosclerosis in Systemic Lupus Erythematosus, Rheumatology (Sunnyvale) Suppl 5 (2014).
[94] K. Ohl, K. Tenbrock, Regulatory T cells in systemic lupus erythematosus, Eur J Immunol 45(2) (2015) 344-55.
[95] M. Zhu, H. Mo, D. Li, X. Luo, L. Zhang, Th17/Treg imbalance induced by increased incidence of atherosclerosis in patients with systemic lupus erythematosus (SLE), Clin Rheumatol 32(7) (2013) 1045-52.
[96] H. Teague, N.N. Mehta, The Link Between Inflammatory Disorders and Coronary Heart Disease: a Look at Recent Studies and Novel Drugs in Development, Curr Atheroscler Rep 18(1) (2016) 3.
[97] B. Yilmazer, T. Sahin, B.O. Unlu, H.M. Kir, A. Cefle, Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity, Rheumatol Int 35(8) (2015) 1385-92.
[98] A.W. Armstrong, S.V. Voyles, E.J. Armstrong, E.N. Fuller, J.C. Rutledge, A tale of two plaques: convergent mechanisms of T-cell-mediated inflammation in psoriasis and atherosclerosis, Exp Dermatol 20(7) (2011) 544-9.
[99] A. von Rossum, I. Laher, J.C. Choy, Immune-mediated vascular injury and dysfunction in transplant arteriosclerosis, Front Immunol 5 (2014) 684.
[100] D. Fanigliulo, P.E. Lazzerini, P.L. Capecchi, C. Ulivieri, C.T. Baldari, F. Laghi-Pasini, Clinically-relevant cyclosporin and rapamycin concentrations enhance regulatory T cell function to a similar extent but with different mechanisms: an in-vitro study in healthy humans, Int Immunopharmacol 24(2) (2015) 276-84.
[101] S.S. Shen-Orr, D. Furman, B.A. Kidd, F. Hadad, P. Lovelace, Y.W. Huang, Y. Rosenberg-Hasson, S. Mackey, F.A. Grisar, Y. Pickman, H.T. Maecker, Y.H. Chien, C.L. Dekker, J.C. Wu, A.J. Butte, M.M. Davis, Defective Signaling in the JAK-STAT Pathway Tracks with Chronic Inflammation and Cardiovascular Risk in Aging Humans, Cell Syst 3(4) (2016) 374-384 e4.
[102] M. Sharma, M.P. Schlegel, M.S. Afonso, E.J. Brown, K. Rahman, A. Weinstock, B.E. Sansbury, E.M. Corr, C. van Solingen, G.J. Koelwyn, L.C. Shanley, L. Beckett, D. Peled, J.J. Lafaille, M. Spite, P. Loke, E.A. Fisher, K.J. Moore, Regulatory T Cells License Macrophage Pro-Resolving Functions During Atherosclerosis Regression, Circ Res 127(3) (2020) 335-353.
[103] M. Ono, H. Yaguchi, N. Ohkura, I. Kitabayashi, Y. Nagamura, T. Nomura, Y. Miyachi, T. Tsukada, S. Sakaguchi, Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1, Nature 446(7136) (2007) 685-9.
[104] Y. Zheng, A. Chaudhry, A. Kas, P. deRoos, J.M. Kim, T.T. Chu, L. Corcoran, P. Treuting, U. Klein, A.Y. Rudensky, Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses, Nature 458(7236) (2009) 351-6.
[105] X.P. Zhong, R. Guo, H. Zhou, C. Liu, C.K. Wan, Diacylglycerol kinases in immune cell function and self-tolerance, Immunol Rev 224 (2008) 249-64.
[106] A.M. Schmidt, T. Zou, R.P. Joshi, T.M. Leichner, M.A. Pimentel, C.L. Sommers, T. Kambayashi, Diacylglycerol kinase zeta limits the generation of natural regulatory T cells, Sci Signal 6(303) (2013) ra101.
[107] I. Gotsman, N. Grabie, R. Gupta, R. Dacosta, M. MacConmara, J. Lederer, G. Sukhova, J.L. Witztum, A.H. Sharpe, A.H. Lichtman, Impaired regulatory T-cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule, Circulation 114(19) (2006) 2047-55.
[108] S. Zhang, L.K. Yong, D. Li, R. Cubas, C. Chen, Q. Yao, Mesothelin virus-like particle immunization controls pancreatic cancer growth through CD8+ T cell induction and reduction in the frequency of CD4+ foxp3+ ICOS- regulatory T cells, PloS one 8(7) (2013) e68303.
[109] D. Rigas, G. Lewis, J.L. Aron, B. Wang, H. Banie, I. Sankaranarayanan, L. Galle-Treger, H. Maazi, R. Lo, G.J. Freeman, A.H. Sharpe, P. Soroosh, O. Akbari, ILC2 Suppression by Regulatory T Cells Attenuates Airway Hyperreactivity and Requires ICOS:ICOS-Ligand Interaction, J Allergy Clin Immunol (2016).
[110] S. Ghourbani Gazar, A. Andalib, M. Hashemi, A. Rezaei, CD4(+)Foxp3(+) Treg and its ICOS(+) subsets in patients with myocardial infarction, Iran J Immunol 9(1) (2012) 53-60.
[111] D.O. Bittner, L. Klinghammer, M. Marwan, J. Schmid, C. Layritz, U. Hoffmann, S. Achenbach, T. Pflederer, Influence of Cardiovascular Risk Factors on the Prevalence of Coronary Atherosclerosis in Patients with Angiographically Normal Coronary Arteries, Acad Radiol 24(5) (2017) 580-586.
[112] R. Mao, W. Xiao, H. Liu, B. Chen, B. Yi, P. Kraj, J.X. She, Systematic evaluation of 640 FDA drugs for their effect on CD4(+)Foxp3(+) regulatory T cells using a novel cell-based high throughput screening assay, Biochem Pharmacol 85(10) (2013) 1513-24.
[113] W.S. Weintraub, S.R. Daniels, L.E. Burke, B.A. Franklin, D.C. Goff, Jr., L.L. Hayman, D. Lloyd-Jones, D.K. Pandey, E.J. Sanchez, A.P. Schram, L.P. Whitsel, Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association, Circulation 124(8) (2011) 967-90.